Most popular recent news http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 07 Jan 2009 12:41:48 +0100 Wed, 07 Jan 2009 12:41:48 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online DOR BioPharma Receives SPA Clearance From the FDA to Begin Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD http://www.lifescience-online.com/DOR_BioPharma_Receives_SPA_Clearance_From_the_FDA_,13610.html?portalPage=Lifescience+Today.News
Area :
Immunomodulation

Category :
Scientific - Pipeline - Regulatory

Related companies :
DOR BIOPHARMA INC

Related drugs :
ORAL BECLOMETHASONE DIPROPIONATE


]]> Mon, 05 Jan 2009 13:52:29 GMT News Genta Incorporated (GNTA) Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral Taxane in Clinical Development http://www.lifescience-online.com/Genta_Incorporated__GNTA__Summarizes_Phase_2_Activ,13619.html?portalPage=Lifescience+Today.News
Area :
Oncology

Category :
Scientific - Pipeline - Regulatory

Related companies :
Genta Inc

Related drugs :
DJ-927


]]> Sun, 04 Jan 2009 23:00:00 GMT News BioDelivery Sciences Closes $6 Million Transaction with Meda http://www.lifescience-online.com/BioDelivery_Sciences_Closes__6_Million_Transaction,13608.html?portalPage=Lifescience+Today.News
Category :
Scientific - Pipeline - Regulatory

Related companies :
BIODELIVERY SCIENCES INTERNATIONAL INC
MEDA AB

Related drugs :
TRANSMUCOSAL (BEMA) FENTANYL


]]> Mon, 05 Jan 2009 12:12:53 GMT News DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis http://www.lifescience-online.com/DOR_BioPharma_Obtains_Fast_Track_Designation_for_D,13631.html?portalPage=Lifescience+Today.News
Area :
Oncology

Category :
Scientific - Pipeline - Regulatory

Related companies :
DOR BIOPHARMA INC

Related drugs :
TIME-RELEASE ORAL BECLOMETHASONE DIPROPIONATE


]]> Tue, 06 Jan 2009 12:09:45 GMT News YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER http://www.lifescience-online.com/YM_BIOSCIENCES_RECEIVES_CLEARANCE_TO_INITIATE_RAND,13625.html?portalPage=Lifescience+Today.News
Area :
Oncology

Category :
Scientific - Pipeline - Regulatory

Related companies :
YM BIOSCIENCES INC

Related drugs :
NIMOTUZUMAB


]]> Sun, 04 Jan 2009 23:00:00 GMT News Idera Pharmaceuticals Announces Publication of Studies on Chemistry of Novel Antagonists for Toll-like Receptors 7 and 9 http://www.lifescience-online.com/Idera_Pharmaceuticals_Announces_Publication_of_Stu,13609.html?portalPage=Lifescience+Today.News
Category :
Scientific - Pipeline - Regulatory

Related companies :
Idera Pharmaceuticals Inc

Related drugs :
TLR-7,8,9 AGONISTS


]]> Mon, 05 Jan 2009 13:41:49 GMT News Endo Pharmaceuticals (ENDP) To Buy Indevus Pharmaceuticals, Inc. (IDEV) for $370 Million in Cash http://www.lifescience-online.com/Endo_Pharmaceuticals__ENDP__To_Buy_Indevus_Pharmac,13611.html?portalPage=Lifescience+Today.News
Category :
Changes and Acquisitions

Related companies :
ENDO PHARMACEUTICALS HOLDINGS INC
INDEVUS PHARMACEUTICALS INC


]]> Sun, 04 Jan 2009 23:00:00 GMT News YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE http://www.lifescience-online.com/YM_BIOSCIENCES__NIMOTUZUMAB_SELECTED_FOR_MULTINATI,13624.html?portalPage=Lifescience+Today.News
Area :
Oncology

Category :
Scientific - Pipeline - Regulatory

Related companies :
YM BIOSCIENCES INC

Related drugs :
NIMOTUZUMAB


]]> Sun, 04 Jan 2009 23:00:00 GMT News